Use of Atropine in Tredmill Stress Testing
Information source: HaEmek Medical Center, Israel
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Chest Pain
Intervention: Atropine (Drug)
Phase: Phase 3
Sponsored by: HaEmek Medical Center, Israel
The aim of this study is to evaluate the Safety and feasibility of atropine added during
treadmill stress testing in patients with chronotropic incompetence or poor exercise
Our hypothesis is that we can increase heart rate by using atropin in these patients, so we
will achieve more conclusive results.
Official title: Safety and Feasibility of Atropine Added During Treadmill Stress Testing in Patients With Chronotropic Incompetence or Poor Exercise Capacity.
Study design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Primary outcome: 1- To characterize patients who can't achieve target heart rate at treadmill exercise test.2- To evaluate atropine added during treadmill stress testing in order to increase heart rate and achieave conclusive test.
Minimum age: 18 Years.
Maximum age: N/A.
- Patients with chest pain without evidence of ischemia eligible for exercise test.
- Age> 18 years old
- Patients with LBBB
- Unstable Angina
- Recent Myocardial Infarction
- Un controlled Arrythmia
- Congestive heart faliure
- Severe symptomatic valvular heart disease
- Acute Pulmonary Embolism
- Acute perimyocarditis
- Acute aortic dissection
- Lt main stenosis
- Severe hypertention (Systolic> 200 mmHg; Diastolic > 100 mmHg)
- Obstructiove abnormalities
- Psychiatric disorders
- High degree AV Block
Locations and Contacts
Heart Institute, Ha'Emek Medical Center, Afula 18100, Israel
Starting date: December 2007
Last updated: July 24, 2015